Q2 2025 Holdings
Filed 2025-08-14 | 111 holdings | $426.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $27.2M | 1,620,990 | 6.4% |
| Nova LTD(NVMI) | COM | M7516K103 | $20.9M | 75,836 | 4.9% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $16.6M | 200,000 | 3.9% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $14.7M | 1,571,564 | 3.5% |
| Tower Semiconductor LTD(TSEM) | SHS NEW | M87915274 | $11.5M | 264,722 | 2.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $10.8M | 326,718 | 2.5% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $10.6M | 219,515 | 2.5% |
| Biogen Inc(BIIB) | COM | 09062X103 | $10.4M | 82,738 | 2.4% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $9.4M | 135,060 | 2.2% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $9.0M | 11,540 | 2.1% |
| Nvidia Corporation(NVDA) | COM | 67066G104 | $8.6M | 54,515 | 2.0% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $8.5M | 419,540 | 2.0% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $7.3M | 105,677 | 1.7% |
| Amazon COM Inc(AMZN) | COM | 023135106 | $7.1M | 32,441 | 1.7% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $6.7M | 138,001 | 1.6% |
| Ultragenyx Pharmaceutical in(RARE)Call | COM | 90400D108 | $6.6M | 180,600 | 1.5% |
| Ormat Technologies Inc(ORA) | COM | 686688102 | $6.5M | 78,000 | 1.5% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $6.5M | 480,974 | 1.5% |
| Forte Biosciences Inc(FBRX) | COM NEW | 34962G208 | $6.4M | 495,109 | 1.5% |
| Meta Platforms Inc(META) | CL A | 30303M102 | $6.3M | 8,526 | 1.5% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $6.2M | 40,831 | 1.5% |
| Moonlake Immunotherapeutics(MLTX)Call | CLASS A ORD | 61559X104 | $5.9M | 125,000 | 1.4% |
| Microsoft Corp(MSFT) | COM | 594918104 | $5.9M | 11,792 | 1.4% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $5.7M | 990,718 | 1.3% |
| Ormat Technologies Inc | DEBT 2.500% 7/1 | 686688AC6 | $5.6M | 5,037,000 | 1.3% |
| Pharvaris N V(PHVS) | COM | N69605108 | $5.5M | 309,931 | 1.3% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $5.3M | 1,959,610 | 1.2% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $5.0M | 335,333 | 1.2% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $4.7M | 25,256 | 1.1% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $4.7M | 122,000 | 1.1% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $4.6M | 109,757 | 1.1% |
| Novartis AG(NVSN) | SPONSORED ADR | 66987V109 | $4.5M | 37,000 | 1.1% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $4.4M | 799,957 | 1.0% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $4.4M | 356,453 | 1.0% |
| Annexon Inc(ANNX) | COM | 03589W102 | $4.2M | 1,764,387 | 1.0% |
| Praxis Precision Medicines I(PRAX)Call | COM NEW | 74006W207 | $4.2M | 100,000 | 1.0% |
| Ishares TR(TLT)Call | 20 YR TR BD ETF | 464287432 | $4.1M | 47,000 | 1.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $4.1M | 256,743 | 1.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $4.0M | 394,693 | 0.9% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $3.8M | 48,600 | 0.9% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $3.8M | 174,900 | 0.9% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $3.8M | 87,108 | 0.9% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $3.6M | 100,085 | 0.9% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $3.6M | 126,000 | 0.8% |
| Alpha Cognition Inc(ACOG) | COM NEW | 02074J501 | $3.5M | 376,649 | 0.8% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $3.4M | 751,447 | 0.8% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $3.3M | 398,309 | 0.8% |
| Applied Matls Inc(AMAT) | COM | 038222105 | $3.3M | 18,000 | 0.8% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $3.2M | 202,996 | 0.8% |
| Immatics N.v(IMTX) | SHS | N44445109 | $3.1M | 583,105 | 0.7% |